{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:59:45Z","timestamp":1783457985405,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Humacyte Inc"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Peripheral vascular trauma occurs as 10% of trauma injuries in combat settings. Its treatment in a combat setting is associated with challenges such as increased risk of infection, increased time to treatment, and lack of availability of medical personnel to perform vascular surgery. Currently, the autologous great saphenous vein or synthetic vessels such as Dacron or Gore-Tex (Teflon) are used to treat peripheral vascular trauma. Unfortunately, these options may neither be available nor advisable because of injury to the native vasculature or the increased risk of infection. Thus, an unmet medical need exists for peripheral vascular trauma among wounded military personnel. An alternative for autologous vein or synthetic vessel grafts mechanically similar to native vasculature and with increased infection resistance compared to synthetic alternatives is needed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>This multicenter, retrospective, observational study examines the use of the acellular tissue-engineered vessel (ATEV) for the treatment of peripheral vascular trauma in a combat setting in Ukraine. The ATEV is an acellular engineered human artery, manufactured from human vascular cells and then decellularized, generating an off-the-shelf conduit that can be immediately available for treatment of arterial injuries. A 1-year Humanitarian effort spanning from June 2022 to May 2023 treated a total of 19 patients suffering extremity arterial injuries with the ATEV in Ukraine. Retrospective data were collected for efficacy and safety outcomes in 17 of these patients, of whom 14 suffered battlefield injuries including gunshots, blast, and shrapnel-related trauma. The primary objectives were to evaluate the safety and efficacy of the Humacyte ATEVs that were implanted for arterial replacement or reconstruction in patients sustaining vascular trauma, and to determine the 30-day rate of primary ATEV patency. The secondary objectives were to determine the rates of ATEV infection, amputation, mortality, and adverse events of special interest related to the ATEV, to assess ATEV durability, and to determine the 30-day limb salvage, infection free time, and patency of the human acellular vessel regardless of interventions. The hypothesis was that ATEVs would achieve similar patency, infection-free rate, limb salvage, and safety outcomes as current standards of care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>After up to 18 total months of data collection in 17 subjects, ATEVs patency was 87.1% (95% CI, 42.5\u201397.8) up to 18\u2009months. The infection-free rate for the ATEV conduits was 100%. Limb salvage and survival rates were also 100% up to 18\u2009months. Overall, ATEV grafts were well tolerated, with no instances of immunological rejection. In two subjects, the ATEV was abandoned: in one case because of thrombosis, and in the other because of damage to the ATEV caused by remaining shrapnel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>ATEV functioned as intended in the treatment of acute and combat-related vascular injuries. Conduit infection rate and amputations of the treated limbs were zero. Patency rates were acceptable, and losses of patency did not lead to loss of the treated limb. This study characterizes the first of its kind, cell-derived biologic engineered artery for use in civilian and military personnel who are injured during combat.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/milmed\/usaf160","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T07:22:09Z","timestamp":1744701729000},"page":"288-296","source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the Safety and Efficacy of Humacyte Acellular Tissue-Engineered Vessel in a Real-World Combat Setting: A Retrospective Observational Multicenter Study"],"prefix":"10.1093","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2380-439X","authenticated-orcid":false,"given":"Shamik","family":"Parikh","sequence":"first","affiliation":[{"name":"Humacyte Global, Inc. , Durham, NC 27713,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Sokolov","sequence":"additional","affiliation":[{"name":"Department of Surgery, Dnipro State Medical University , Dnipro 49069,","place":["Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasyl","family":"Shaprynskyi","sequence":"additional","affiliation":[{"name":"State Institution of Science, CHIT, State Administrative Department , Kyiv 01014,","place":["Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh","family":"Skupyy","sequence":"additional","affiliation":[{"name":"Center of Cardiovascular Surgery, Vinnytsia Regional Clinical Hospital , Vinnytsia 21028,","place":["Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksandr","family":"Stanko","sequence":"additional","affiliation":[{"name":"Department of Surgery, Odessa Regional Clinical Hospital , Odessa 65025,","place":["Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhii","family":"Yurets","sequence":"additional","affiliation":[{"name":"Center of Cardiovascular Surgery, Vinnytsia Regional Clinical Hospital , Vinnytsia 21028,","place":["Ukraine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Yurkova","sequence":"additional","affiliation":[{"name":"Humacyte Global, Inc. , Durham, NC 27713,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fadri","sequence":"additional","affiliation":[{"name":"Humacyte Global, Inc. , Durham, NC 27713,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Niklason","sequence":"additional","affiliation":[{"name":"Humacyte Global, Inc. , Durham, NC 27713,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"2025091919341942100_R1","volume-title":"StatPearls","author":"Huber","year":"2023"},{"issue":"8","key":"2025091919341942100_R2","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/acem.13227","article-title":"Accuracy of physical examination, ankle-brachial index, and ultrasonography in the diagnosis of arterial injury in patients with penetrating extremity trauma: a systematic review and meta-analysis","volume":"24","author":"deSouza","year":"2017","journal-title":"Acad Emerg Med"},{"issue":"6","key":"2025091919341942100_R3","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/SLA.0b013e31820752e3","article-title":"The epidemiology of vascular injury in the wars in Iraq and Afghanistan","volume":"253","author":"White","year":"2011","journal-title":"Ann Surg"},{"issue":"3","key":"2025091919341942100_R4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/TA.0b013e3182994b48","article-title":"Western Trauma Association critical decisions in trauma: evaluation and management of peripheral vascular injury, part II","volume":"75","author":"Feliciano","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"issue":"20","key":"2025091919341942100_R5","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1161\/CIR.0000000000000457","article-title":"Vascular graft infections, mycotic aneurysms, and endovascular infections: a scientific statement from the American Heart Association","volume":"134","author":"Wilson","year":"2016","journal-title":"Circulation"},{"issue":"2","key":"2025091919341942100_R6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/XCS.0000000000000707","article-title":"Putting medical boots on the ground: lessons from the war in Ukraine and applications for future conflict with near-peer adversaries","volume":"237","author":"Epstein","year":"2023","journal-title":"J Am Coll Surg"},{"issue":"485","key":"2025091919341942100_R7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau6934","article-title":"Bioengineered human acellular vessels recellularize and evolve into living blood vessels after human implantation","volume":"11","author":"Kirkton","year":"2019","journal-title":"Sci Transl Med"},{"key":"2025091919341942100_R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvssci.2023.100120","article-title":"Biological mechanisms of infection resistance in tissue engineered blood vessels compared to synthetic expanded polytetrafluoroethylene grafts","volume":"4","author":"Wang","year":"2023","journal-title":"JVS Vasc Sci"},{"key":"2025091919341942100_R9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jss.2017.08.035","article-title":"Susceptibility of ePTFE vascular grafts and bioengineered human acellular vessels to infection","volume":"221","author":"Kirkton","year":"2018","journal-title":"J Surg Res"},{"issue":"1","key":"2025091919341942100_R10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mayocp.2023.05.004","article-title":"Outcomes of arterial bypass with the human acellular vessel for chronic limb-threatening ischemia performed under the FDA expanded access program","volume":"99","author":"Sen","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"2025091919341942100_R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100650","article-title":"Use of bioengineered human acellular vessels to treat traumatic injuries in the Ukraine-Russia conflict","volume":"29","author":"Sokolov","year":"2023","journal-title":"Lancet Reg Health Eur"},{"issue":"68","key":"2025091919341942100_R12","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001426","article-title":"Readily available tissue-engineered vascular grafts","volume":"3","author":"Dahl","year":"2011","journal-title":"Sci Transl Med"},{"issue":"10032","key":"2025091919341942100_R13","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(16)00557-2","article-title":"Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials","volume":"387","author":"Lawson","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"2025091919341942100_R14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s13239-011-0049-3","article-title":"Tissue engineering of blood vessels: functional requirements, progress, and future challenges","volume":"2","author":"Kumar","year":"2011","journal-title":"Cardiovasc Eng Technol"},{"issue":"5","key":"2025091919341942100_R15","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1161\/ATVBAHA.123.318239","article-title":"Hemodynamics and wall mechanics of vascular graft failure","volume":"44","author":"Szafron","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2025091919341942100_R16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1001\/jamasurg.2024.4893","article-title":"Bioengineered Human Arteries for the Repair of Vascular Injuries","volume":"160(2)","author":"Moore","year":"2025","journal-title":"JAMA Surgery"},{"issue":"6","key":"2025091919341942100_R17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jvs.2023.08.123","article-title":"Investigation of center-specific saphenous vein utilization rates in femoral popliteal artery bypass and associated impact of conduit on outcomes","volume":"78","author":"Parker","year":"2023","journal-title":"J Vasc Surg"},{"issue":"1","key":"2025091919341942100_R18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1024\/0301-1526\/a000008","article-title":"Dacron or ePTFE graft for above-knee femoropopliteal bypass reconstruction. A bi-centre randomised study","volume":"39","author":"Davidovic","year":"2010","journal-title":"Vasa"},{"key":"2025091919341942100_R19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvssci.2022.11.001","article-title":"Six-year outcomes of a phase II study of human-tissue engineered blood vessels for peripheral arterial bypass","volume":"4","author":"Gutowski","year":"2022","journal-title":"JVS Vasc Sci"}],"container-title":["Military Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/Supplement_2\/288\/64288168\/usaf160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/milmed\/article-pdf\/190\/Supplement_2\/288\/64288168\/usaf160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T23:34:21Z","timestamp":1758324861000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/milmed\/article\/190\/Supplement_2\/288\/8256309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":19,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2025,9,16]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/milmed\/usaf160","relation":{},"ISSN":["0026-4075","1930-613X"],"issn-type":[{"value":"0026-4075","type":"print"},{"value":"1930-613X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,9,1]]}}}